ISB News

Microsoft’s Craig Mundie Joins ISB Board

ISB announced three new board of directors members this morning. The full press release is here.

  • Douglas Howe: Howe is the president and founder of Touchstone Corporation, a Seattle-based commercial real estate company that focuses on the development of urban infill projects and leads the industry in designing and constructing high-performance, sustainable green buildings. More info
  • Craig Mundie: Mundie is the senior advisor to Steve Ballmer, CEO of Microsoft Corp. He works on key strategic projects within the company, as well as with government and business leaders around the world on technology policy, regulation and standards. More info
  • Dr. Drew Senyei: Senyei is the managing director of Enterprise Partners Venture Capital, the largest venture firm in Southern California. He specializes in building emerging life sciences and healthcare companies. More info

In the News: Geekwire.com posted about the news.

“We’re getting a better idea of how longtime Microsoft executive Craig Mundie is going to spend some of his time after he retires from the software giant next year. Mundie, the former chief research and strategy officer at Microsoft who now serves as an advisor to Steve Ballmer, was just named to the board of the Institute for Systems Biology.”

 

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.